Radiopharmaceutical therapy and molecular imaging—together known as Theranostics—are gaining significant traction worldwide. Even though Theranostics dates back to the early 1940s, a rapid ...

Molecular imaging and therapy uses small amounts of radioactive substances to detect or treat disease. At Fred Hutch Cancer Center, our molecular imaging and therapy specialists are part of nearly ...

SHREVEPORT, La. -- Twenty-seven years ago, BRF placed Shreveport on the map as a pioneer in molecular imaging by opening Louisiana’s first positron emission tomography (PET) center. Today, BRF is ...

Molecular imaging may be best for capturing renal transplant complications Study reveals that clinicians can detect a broad range of post renal-transplant complications using a state-of- ...

SHREVEPORT, La. – BRF’s Center for Molecular Imaging and Therapy (CMIT) is the first positron emission tomography (PET) center in Louisiana to offer the latest imaging procedure for breast cancer ...

Molecular imaging may improve the success rate of a new therapy for patients with advanced heart disease, according to a study unveiled at SNM's 57th Annual Meeting.

A handful of people make up the core of your molecular imaging and therapy team. You will have a nuclear medicine specialist who interprets your imaging scans. They also design and manage any ...

The construction of this $19.5 million facility was accomplished through the funding by BRF, the State of Louisiana, state and nation organizations, community groups and private donors.

CULVER CITY, Calif., Sept. 12, 2019 /PRNewswire-PRWeb/ -- The World Molecular Imaging Society (WMIS) recently concluded its annual Congress in Montreal, highlighting new discoveries focused on the ...

A $19.5 million, 23,000 square-foot Center for Molecular Imaging and Therapy has opened in Shreveport. A $19.5 million, 23,000 square-foot Center for Molecular Imaging and Therapy has opened in ...